Results 21 to 30 of about 9,597 (210)

Oral vaccines for preventing cholera [PDF]

open access: yesCochrane Database of Systematic Reviews, 2010
This review is superseded by the published Cochrane Review, Saif‐Ur‐Rahman 2024 [https://doi.org/10.1002/14651858.CD014573], which considers only the oral killed vaccines because the live oral vaccines do not have World Health Organization (WHO) prequalification. Saif‐Ur‐Rahman 2024 also considered only currently available WHO pre‐qualified oral killed
Sinclair, David   +4 more
openaire   +3 more sources

Oral Vaccines Against Cholera [PDF]

open access: yesClinical Infectious Diseases, 2011
The current seventh pandemic of cholera, caused by serogroup O1, El Tor biotype, has now involved almost the entire developing world. The ongoing dynamic epidemiology of cholera, involving evolution of new strains, prolonged and more frequent epidemics, increased antimicrobial resistance, and awareness of the role of climate change upon the global ...
Sunheang, Shin   +3 more
openaire   +2 more sources

Immunogenicity of cholera vaccination in children with inflammatory bowel disease

open access: yesHuman Vaccines & Immunotherapeutics, 2021
The cholera vaccine can protect patients with inflammatory bowel disease (IBD) against both cholera and travelers’ diarrhea. However, both immunosuppressive treatment and IBD can affect its vaccine immunogenicity.
Łukasz Dembiński   +5 more
doaj   +1 more source

Stemming cholera tides in Zimbabwe through mass vaccination

open access: yesInternational Journal of Infectious Diseases, 2020
Background: In 2018, Zimbabwe declared another major cholera outbreak a decade after recording one of the worst cholera outbreaks in Africa. Methods: A mathematical model for cholera was used to estimate the magnitude of the cholera outbreak and ...
Zindoga Mukandavire   +5 more
doaj   +1 more source

Sociocultural determinants of anticipated oral cholera vaccine acceptance in three African settings : a meta-analytic approach [PDF]

open access: yes, 2016
Controlling cholera remains a significant challenge in Sub-Saharan Africa. In areas where access to safe water and sanitation are limited, oral cholera vaccine (OCV) can save lives. Establishment of a global stockpile for OCV reflects increasing priority
Merten, Sonja   +19 more
core   +1 more source

Social and cultural features of vaccine acceptance and cost-effectiveness of an oral cholera mass vaccination campaign in Zanzibar [PDF]

open access: yes, 2012
Classical cholera control is based on prevention—safe water, sanitation and education of people on the importance of hygiene and diarrheal diseases—health system preparedness and a timely response to provide appropriate treatment in the event of an ...
Schätti Zundel, Christian
core   +1 more source

Improving community coverage of oral cholera mass vaccination campaigns: lessons learned in Zanzibar [PDF]

open access: yes, 2012
BACKGROUND: Recent research in two cholera-endemic communities of Zanzibar has shown that a majority (?94%) of the adult population was willing to receive free oral cholera vaccines (OCVs). Since OCV uptake in the 2009 campaign reached only ?50% in these
Claire-Lise Chaignat   +26 more
core   +1 more source

Costs of illness due to cholera, costs of immunization and cost-effectiveness of an oral cholera mass vaccination campaign in Zanzibar [PDF]

open access: yes, 2012
BACKGROUND: The World Health Organization (WHO) recommends oral cholera vaccines (OCVs) as a supplementary tool to conventional prevention of cholera. Dukoral, a killed whole-cell two-dose OCV, was used in a mass vaccination campaign in 2009 in Zanzibar.
Claire-Lise Chaignat   +31 more
core   +1 more source

Comparing sociocultural features of cholera in three endemic African settings [PDF]

open access: yes, 2013
Cholera mainly affects developing countries where safe water supply and sanitation infrastructure are often rudimentary. Sub-Saharan Africa is a cholera hotspot.
Merten, Sonja   +17 more
core   +1 more source

Home - About - Disclaimer - Privacy